MannKind Corp (MNKD) stock forecast · rev $199.5M
MannKind Corp (MNKD) is a biotechnology company listed on US.
This MNKD forecast page states what the cached financials imply — not a price target and not a guarantee. MannKind Corp outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported MNKD revenue for 2026-06-30 was $199.5M. Net income was -$35.7M. MNKD currently screens at market cap $1.28B.
Period-over-period revenue change is not in cache for MNKD, so this page does not invent a growth rate.
MNKD currently screens at market cap $1.28B. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next MNKD 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the MNKD stock page.
Not investment advice.